Clinical Trial Update: Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CU104 in moderate-severe ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• CU104

Snippet

Sponsor: Curacle Co., Ltd. | Conditions: Ulcerative Colitis | Phase 2 | Status: UNKNOWN